000 01489 a2200409 4500
005 20250516005257.0
264 0 _c20110124
008 201101s 0 0 eng d
022 _a1083-351X
024 7 _a10.1074/jbc.M110.148155
_2doi
040 _aNLM
_beng
_cNLM
100 1 _avan Lith, Marcel
245 0 0 _aHLA-DP, HLA-DQ, and HLA-DR have different requirements for invariant chain and HLA-DM.
_h[electronic resource]
260 _bThe Journal of biological chemistry
_cDec 2010
300 _a40800-8 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntigen Presentation
_xgenetics
650 0 4 _aBerylliosis
_xgenetics
650 0 4 _aHLA-D Antigens
_xgenetics
650 0 4 _aHLA-DP Antigens
_xgenetics
650 0 4 _aHLA-DQ Antigens
_xgenetics
650 0 4 _aHLA-DR Antigens
_xgenetics
650 0 4 _aHeLa Cells
650 0 4 _aHepatitis B
_xgenetics
650 0 4 _aHumans
650 0 4 _aMolecular Chaperones
_xgenetics
650 0 4 _aMyasthenia Gravis
_xgenetics
650 0 4 _aPeptides
_xgenetics
650 0 4 _aProtein Multimerization
_ximmunology
650 0 4 _aProtein Transport
_xphysiology
650 0 4 _aRisk Factors
650 0 4 _aViral Proteins
_xgenetics
700 1 _aMcEwen-Smith, Rosanna M
700 1 _aBenham, Adam M
773 0 _tThe Journal of biological chemistry
_gvol. 285
_gno. 52
_gp. 40800-8
856 4 0 _uhttps://doi.org/10.1074/jbc.M110.148155
_zAvailable from publisher's website
999 _c20262298
_d20262298